Latest Breaking News On - Dean petkanas - Page 1 : comparemela.com

Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS

The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing funding specifically in the Development of KLS-13019 for Neuropathic

United statesAmericanKostenloser wertpapierhandelKathryn brownLouie tomaNeuropathix incPennsylvania biotechnology centerNational institutes of healthDrug administrationCompany twitterInitiative helping end addictionPfizerSecurities exchangeNational instituteHelping end addiction long termDean petkanas

Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS

Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesAmericanKathryn brownLouie tomaNeuropathix incPennsylvania biotechnology centerNational institutes of healthDrug administrationCompany twitterInitiative helping end addictionPfizerSecurities exchangeNational instituteHelping end addiction long termDean petkanasNational institutes

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritishKathryn brownLouie tomaNeuropathix incSubstance abuse researchPennsylvania biotechnology centerNational institute of healthNational institutes of healthDrug administrationCompany twitterSecurities exchangeNational institute of neurological disordersNational institutePublished preclinical data shows

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company's Scientific Advisory Board

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company's Scientific Advisory Board
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

ItalyCaliforniaUnited statesIrvineItalianLouise turner arnoldDaniele piomelliLouie tomaNeuropathix incPennsylvania biotechnology centerDrug administrationCompany twitterCompany scientific advisory boardItalian institute of technologyCannabinoid researchSecurities exchange

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company's Scientific Advisory Board

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company's Scientific Advisory Board
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.